Ocular Therapeutix, Inc. (OCUL) Net margin 2016–2025
Ocular Therapeutix, Inc. (OCUL) net profit margin by fiscal year — reported net income divided by reported revenue.
-511.9%FY2025 · since FY2016: -2369.0% → -511.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -511.9% | -208.2 pp |
| FY2024 | -303.7% | -165.5 pp |
| FY2023 | -138.1% | -0.2 pp |
| FY2022 | -138.0% | -122.9 pp |
| FY2021 | -15.1% | +879.2 pp |
| FY2020 | -894.3% | +1149.0 pp |
| FY2019 | -2043.3% | +970.6 pp |
| FY2018 | -3014.0% | +282.2 pp |
| FY2017 | -3296.2% | -927.2 pp |
| FY2016 | -2369.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice